biOasis Technologies Ord Shs V.BTI.H

Aposense and siRNA

[JDavenport]

This collaborative deal may have come about through an introduction of Bioasis to Aposense through the Chiesi deal. Chiesi's partner, Protalix, shares a director, Amos Bar Shalev, with Aposense.

However it happened, it's a very confirming development. As Shakespears said, "We are advertised by our loving friends."

This collaboration may take a while to produce any news, but then, Chiesi hasn't produced any news and yet here we are with another gig. (Frankly, it's the Bioasis pipeline that gets me excited in the near term.)

Aposense has multiple siRNA things going on and since they use the plural, "drugs", in this PR, I'm going to add two more drug/disease combinations to my list. I now have 25 on the list. The Aposense drug/disease combinations are unknown except that it looks like they will employ siRNA technologies, a very hot technology and topic these days. 

jd

[JDavenport]

I want to point out, given the nonsense on this forum, that I place more value in Aposense's opinion about Bioasis and xB3 than I do in the opinions of the Stockhouse characters that I have placed on ignore. Just saying, duh! jd

[barsax]

...well I'm not so sure.  I mean the Aposense Science President - Prof Roger Kornberg - won a Nobel Prize....but that was in 2006, so, you know...what have you done for me lately... ...just kidding... Professor Kornberg served as a director of Teva Pharmaceutical Industries Ltd. from 2007 through 2013. Professor Kornberg is a member of the U.S. National Academy of Sciences and the

[JDavenport]

Yeah, what would he know about the price of genes at Walmart. jd